- Home
- CTNT vs OGEN Comparison
CTNT vs OGEN Comparison
Compare CTNT & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- OGEN
- Stock Information
- Founded
- CTNT 2016
- OGEN 1996
- Country
- CTNT United States
- OGEN United States
- Employees
- CTNT N/A
- OGEN N/A
- Industry
- CTNT
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- OGEN Health Care
- Exchange
- CTNT Nasdaq
- OGEN Nasdaq
- Market Cap
- CTNT 6.1M
- OGEN 5.4M
- IPO Year
- CTNT 2023
- OGEN N/A
- Fundamental
- Price
- CTNT $1.29
- OGEN $1.14
- Analyst Decision
- CTNT
- OGEN
- Analyst Count
- CTNT 0
- OGEN 0
- Target Price
- CTNT N/A
- OGEN N/A
- AVG Volume (30 Days)
- CTNT 326.7K
- OGEN 52.7K
- Earning Date
- CTNT 11-07-2025
- OGEN 11-07-2025
- Dividend Yield
- CTNT N/A
- OGEN N/A
- EPS Growth
- CTNT N/A
- OGEN N/A
- EPS
- CTNT N/A
- OGEN N/A
- Revenue
- CTNT $1,420,060.00
- OGEN N/A
- Revenue This Year
- CTNT $302.80
- OGEN N/A
- Revenue Next Year
- CTNT $22.22
- OGEN N/A
- P/E Ratio
- CTNT N/A
- OGEN N/A
- Revenue Growth
- CTNT N/A
- OGEN N/A
- 52 Week Low
- CTNT $1.12
- OGEN $1.01
- 52 Week High
- CTNT $8.50
- OGEN $18.90
- Technical
- Relative Strength Index (RSI)
- CTNT 32.80
- OGEN 39.04
- Support Level
- CTNT $1.20
- OGEN $1.06
- Resistance Level
- CTNT $1.40
- OGEN $1.22
- Average True Range (ATR)
- CTNT 0.09
- OGEN 0.06
- MACD
- CTNT -0.02
- OGEN -0.01
- Stochastic Oscillator
- CTNT 20.30
- OGEN 21.43
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.